2025 SOLACI Research Grant

By initiative of the board of directors (together with the research department), SOLACI is launching a research grant aimed at improving knowledge and access to endovascular treatments in Latin America.

The 2025 SOLACI Research Grant is open to any LATAM center wishing to participate. A committee composed of the SOLACI Board of Directors and representatives from SOLACI Research will evaluate the submitted proposals and determine which one(s) will be selected to receive the grant.

How to apply for the grant?

To be eligible for the grant, applicants must submit their proposals, which must meet three inclusion criteria:

  • The research must take place in Latin America.
  • Its objective must be either to improve knowledge (e.g., “Prevalence of bicuspid valve disease in patients eligible for TAVI in XXX region”) or to improve access (e.g., “Implementation of an infarction network in rural areas”).
  • The proposal must be feasible. This means that results must be presented within two years of receiving the grant and the budget must not exceed USD 15,000.

For more information, download the complete guide to correctly submit your proposal, including the required steps, documents, and formats.

Steps to follow

  1. Download and complete all required documentation:
  2. Send all attachments in a single email to research@solaci.org.
  3. Proposals will only be accepted in English.
  4. The email must be sent by the principal investigator in charge.
  5. Submit your proposal before the deadline: April 30, 2025.
  6. Final decision: to be published before May 30, 2025.

For more details, carefully read the complete guide to correctly submit the required documentation.

Important*

  • The main manuscript of the study must be published before March 2027.
  • The results must be presented in a special session at the SOLACI Congress 2026.

More articles by this author

ACC 2026: SURViV Trial Results – Exclusive Presentation and Analysis with Dr. Dimytri Siqueira

Following the presentation of the SURViV trial in the Late Breaking Clinical Trials sessions at the American College of Cardiology Congress, Dr. Dimytri Siqueira...

SOLACI Technicians Webinar – Ultrasound Pulses + Calcium = Coronary Lithotripsy

The Latin American Society of Interventional Cardiology (SOLACI) invites you to participate in a new Live SOLACI Webinar specially designed for technicians, nurses, and...

COMPLICAT 2026: Collaborative learning to address complications in congenital and structural heart disease

Free online course in Spanish5 webinars in 2026 COMPLICAT 2026 returns with its second edition, consolidating itself as an innovative academic space dedicated to the...

CHIP LATAM | Chapter 2 – Mexico: Complications Workshop

The Latin American Society of Interventional Cardiology invites the entire medical community to participate in a virtual workshop on complications organized by SOLACI’s Complex...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...